Supriya Lifescience Limited executed a long-term Supply and Sales Agreement (hereinafter "Agreement") on May 23, 2023, with a leading Company in Europe for the supply of Active Pharmaceutical Ingredient (API) for a period of 10 years. The business potential would be approximately INR 400 Million per year at its peak. The peak volumes are expected to happen in Fiscal Year 27.